SRM Equity Partners has successfully sold its portfolio company, Rezolut, specializing in women's outpatient imaging services, to Envision Radiology, aiming to enhance patient care through increased service offerings and operational synergy.
Information on the Target
Rezolut is a prominent provider of outpatient imaging services, specialized in women's imaging. The company operates a comprehensive network of 42 full-modality outpatient imaging centers across several states, including Arizona, California, New Jersey, New Mexico, New York, and Pennsylvania. In addition to its core business, Rezolut also offers mobile women's imaging services, in-house imaging services, and imaging equipment sales and maintenance.
Industry Overview in the Target’s Specific Country
The outpatient imaging services industry in the United States has experienced significant growth, driven by increasing demand for non-invasive diagnostic procedures. As health awareness rises among the population, individuals are more inclined to seek outpatient services, which provide accessibility and convenience compared to traditional hospital settings. As of 2025, the outpatient imaging sector is valued in the billions, and projections indicate a substantial annual growth rate over the next few years.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Technological advancements are also playing a crucial role in shaping the industry, enhancing the quality and speed of imaging services. Innovations such as digital imaging, AI integration, an
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Prime Healthcare → Franciscan Health Olympia Fields
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Bessemer Investors, LLC → Xanitos Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Envision Radiology
invested in
Rezolut
in 2025
in a Buyout deal